Synthego, a recognized leader in CRISPR solutions, announces its formal entry into the molecular and clinical diagnostic reagents sector. Building upon its reputation for rigorous quality, custom ...
Validated clinical efficacy and scalable manufacturing propel exosomes from research discovery to commercial therapeutics.
The market is rapidly transitioning from episodic diagnostics to continuous health monitoring. By 2035, the integration of ...
Waters Corporation is repositioning its growth profile through the acquisition of Becton Dickinson’s (BD) biosciences and ...
Beam Therapeutics jumps 22% after outlining 2026 pipeline goals, including accelerated approval plans for BEAM-302 and a ...
Single-use systems streamline CGT manufacturing by reducing cleaning validation and enabling quick changeovers, essential for ...
Axol Bioscience Ltd. (Axol), a leading provider of induced pluripotent stem cell (iPSC) technologies for drug discovery and disease research, today announced that it has secured $2.8 million (£2.1 ...
Zacks Small Cap Research on MSN
YDES: YD Biopharma is an integrated biotechnology company that is poised to have a transformational year as it expands business operations
YDES YD Bio (NASDAQ:YDES) is an integrated biotechnology company that combines diagnostics, precision medicine, and ...
Amsbio has launched a new range of Adeno-Associated Virus (AAV) reference standards to help researchers optimise AAV ...
The surge in diagnostic testing is a major growth engine for the hospital supplies market. In the U.S., 14 billion clinical ...
The orbitofrontal cortex (OFC) is critical to identifying task structure and to generalizing appropriately across task states with similar underlying or hidden causes. This capability is at the heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback